WALTHAM, Mass., May 01, 2018 -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it will be participating in the 3rd annual Disruptive Growth & Healthcare Conference in New York City on May 8-9, 2018 sponsored by RHK Capital and ReedSmith. The conference offers an opportunity to discover life science companies focusing on unmet medical needs with disruptive technologies and business models. Those interested in attending the conference should visit http://disruptnyc.com/ for more information.
Shai Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, Inc. will participate in a Pain Management Panel Discussion at 3:00 PM EDT on May 8. At 4:40 PM EDT on May 8 Dr. Gozani will present a business update and commentary on Quell®, the company’s a wearable device for management of chronic pain. A live webcast of the 4:40 PM EDT presentation will be available on NeuroMetrix’ investor relations page.
About NeuroMetrix
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more
information, please visit NeuroMetrix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
About ReedSmith:
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Their long-standing relationships and international outlook make them the go-to partner for speedy resolution of complex transactions, disputes and regulatory matters.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
[email protected]
Source: NeuroMetrix, Inc.


Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Same sparkle, different story: how lab-grown diamonds are transforming the market
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 



